Somatic Mutagenesis with a Sleeping Beauty Transposon System Leads to Solid Tumor Formation in Zebrafish
Open Access
- 21 April 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (4) , e18826
Abstract
Large-scale sequencing of human cancer genomes and mouse transposon-induced tumors has identified a vast number of genes mutated in different cancers. One of the outstanding challenges in this field is to determine which genes, when mutated, contribute to cellular transformation and tumor progression. To identify new and conserved genes that drive tumorigenesis we have developed a novel cancer model in a distantly related vertebrate species, the zebrafish, Danio rerio. The Sleeping Beauty (SB) T2/Onc transposon system was adapted for somatic mutagenesis in zebrafish. The carp ß-actin promoter was cloned into T2/Onc to create T2/OncZ. Two transgenic zebrafish lines that contain large concatemers of T2/OncZ were isolated by injection of linear DNA into the zebrafish embryo. The T2/OncZ transposons were mobilized throughout the zebrafish genome from the transgene array by injecting SB11 transposase RNA at the 1-cell stage. Alternatively, the T2/OncZ zebrafish were crossed to a transgenic line that constitutively expresses SB11 transposase. T2/OncZ transposon integration sites were cloned by ligation-mediated PCR and sequenced on a Genome Analyzer II. Between 700–6800 unique integration events in individual fish were mapped to the zebrafish genome. The data show that introduction of transposase by transgene expression or RNA injection results in an even distribution of transposon re-integration events across the zebrafish genome. SB11 mRNA injection resulted in neoplasms in 10% of adult fish at ∼10 months of age. T2/OncZ-induced zebrafish tumors contain many mutated genes in common with human and mouse cancer genes. These analyses validate our mutagenesis approach and provide additional support for the involvement of these genes in human cancers. The zebrafish T2/OncZ cancer model will be useful for identifying novel and conserved genetic drivers of human cancers.Keywords
This publication has 57 references indexed in Scilit:
- The patterns and dynamics of genomic instability in metastatic pancreatic cancerNature, 2010
- Transposon-based screens for cancer gene discovery in mouse modelsSeminars in Cancer Biology, 2010
- Transgenesis inXenopususing theSleeping Beautytransposon systemDevelopmental Dynamics, 2009
- A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinomaNature Biotechnology, 2009
- Efficient transposition of the Tol2 transposable element from a single-copy donor in zebrafishProceedings of the National Academy of Sciences, 2008
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Oncogenic KRAS Induces Progenitor Cell Expansion and Malignant Transformation in Zebrafish Exocrine PancreasGastroenterology, 2008
- The Tol2kit: A multisite gateway‐based construction kit for Tol2 transposon transgenesis constructsDevelopmental Dynamics, 2007
- Structure-based prediction of insertion-site preferences of transposons into chromosomesNucleic Acids Research, 2006
- Transposon vectors for gene‐trap insertional mutagenesis in vertebratesGenesis, 2004